NCT02242812View on ClinicalTrials.gov

Telmisartan Effectiveness on Left Ventricular Mass Reduction (TELMAR) as Assessed by MRI, in Patients With Mild to Moderate Hypertension

PHASE4TerminatedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 30, 2003

Primary Completion Date

October 31, 2004

Conditions
Hypertension
Interventions
DRUG

Telmisartan

DRUG

Metoprolol succinate

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02242812 - Telmisartan Effectiveness on Left Ventricular Mass Reduction (TELMAR) as Assessed by MRI, in Patients With Mild to Moderate Hypertension | Biotech Hunter | Biotech Hunter